Nanoparticles enhance immune response against cancer in mice

Summary: Vanderbilt University researchers have created nanoparticles that enhance the immune response against melanoma and breast cancer in mice. Published in ACS Nano, the study focuses on lipid nanoparticles delivering a nucleic acid that activates the RIG-I pathway, typically used to combat viral infections. This approach shows promise for future human cancer treatments, building on the success of mRNA vaccines.

Full article